These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Clinical evaluation of Cernilton in benign prostatic hypertrophy].
    Author: Hayashi J, Mitsui H, Yamakawa G, Suga A, Kai A, Shimabukuro T, Yanagi K, Fujisawa S, Takihara H, Kaneda Y.
    Journal: Hinyokika Kiyo; 1986 Jan; 32(1):135-41. PubMed ID: 2421560.
    Abstract:
    Twenty patients with benign prostatic hypertrophy were treated with Cernilton, 6 tablets a day for an average of 13.2 weeks. Subjective effectiveness was observed in the improvement of sense of residual urine (92%), retardation (86%), night frequency (85%), strain on urination (56%), protraction (53%) and forceless urinary stream (53%). The overall subjective effectiveness was 80% of patients, and the overall objective effectiveness was 54% of patients. Night frequency, residual urine volume and tidal urine volume were improved significantly. The overall effectiveness was 80%. No side effects were observed.
    [Abstract] [Full Text] [Related] [New Search]